Australia - English - Department of Health (Therapeutic Goods Administration)

natural bio pty limited - d-alpha-tocopheryl acid succinate, quantity: 4.5 mg; lutein, quantity: 5 mg; betacarotene, quantity: 0.5 mg - tablet, chewable - excipient ingredients: magnesium stearate; maltodextrin; sucralose; colloidal anhydrous silica; glucose monohydrate; fructose; flavour; maize starch; ascorbyl palmitate; gelatin; maize oil; dl-alpha-tocopherol; sucrose - antioxidant/reduce free radicals formed in the body ; maintain/support healthy eye function ; maintain/support eye health ; helps maintain/support eye macula health ; helps maintain/support eye retina health ; maintain/support healthy eyesight/vision ; maintain/support general health and wellbeing ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support (state vitamin/mineral/nutrient) levels in the body

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

medreich plc - amiodarone hydrochloride - oral tablet - 200mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

noumed life sciences ltd - amiodarone hydrochloride - oral tablet - 200mg

United States - English - NLM (National Library of Medicine)

bath & body works, inc. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic decrease bacteria on hands.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - hydrochlorothiazide, quantity: 50 mg; amiloride hydrochloride dihydrate, quantity: 5 mg - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate dihydrate; lactose monohydrate; maize starch; guar gum; sunset yellow fcf; pregelatinised maize starch; magnesium stearate - indicated in the treatment of patients with oedema of cardiac origin; hepatic cirrhosis with ascites; hypertension in whom potassium depletion might be anticipated. moduretic, with its combination of amiloride hcl and hydrochlorothiazide, minimises the possibility of the development of excessive potassium loss in patients during vigorous diuresis for prolonged periods. moduretic, with its built-in potassium sparing agent, is especially indicated in those conditions where the positive effect on potassium balance is particularly important. moduretic may be used alone, or as an adjunct to other antihypertensive drugs. since it enhances the action of these agents, the dosage of these antihypertensive drugs may need to be reduced to avoid the risk of excessive drop in blood pressure.

Israel - English - Ministry of Health

rafa laboratories ltd - morphine sulfate - tablets controlled release - morphine sulfate 30 mg - morphine - morphine - prolonged relief of severe pain.

Israel - English - Ministry of Health

rafa laboratories ltd - morphine sulfate - tablets controlled release - morphine sulfate 10 mg - morphine - morphine - prolonged relief of severe pain.

Israel - English - Ministry of Health

taro pharmaceutical industries ltd - oxycodone hydrochloride; paracetamol - tablets - oxycodone hydrochloride 10 mg; paracetamol 325 mg - paracetamol - paracetamol - for the relief of moderate to moderately severe pain.

Israel - English - Ministry of Health

taro pharmaceutical industries ltd - oxycodone hydrochloride; paracetamol - tablets - paracetamol 325 mg; oxycodone hydrochloride 5 mg - paracetamol, combinations with psycholeptics - paracetamol, combinations with psycholeptics - for the relief of moderate to moderately severe pain.

Ireland - English - HPRA (Health Products Regulatory Authority)

roche products limited - clonazepam, magnesium stearate ph.eur. - tablets - 0.5 milligram - benzodiazepine derivatives